Prism Medico and Pharmacy Limited - chemicals and materials in Kala Amb, Himachal Pradesh, India. FY 2026 financials & compliance.
CIN L24100HP2002PLC009299 Incorporated 22 March 2002 ROC Himachal Pradesh HQ Kala Amb, Himachal Pradesh, India
Active Listed - BSE: 512217 Public Limited Company chemicals and materials
Market Cap
₹47.44 Cr
PRISMMEDI · BSE
Share Price
₹35.00
+0.06% today
Revenue
₹54.43 Cr
FY 2018-19 · +138.7% YoY
EBITDA
₹0.12 Cr
Margin 0.2%
Net Profit
₹0.16 Cr
FY 2018-19 · +633.3% YoY
ROE
1.1%
ROCE 1.6%
Debt / Equity
0.17
Interest cover -42.3x
Authorised capital
₹25 Cr
Registered with MCA

About Prism Medico and Pharmacy Limited

Data last updated:

Prism Medico and Pharmacy Limited is a public limited company based in Kala Amb, Himachal Pradesh, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 22 March 2002 and has been in existence for over 24 years.

The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN L24100HP2002PLC009299. Its GSTIN is 02AAACW0505H1Z0 (Himachal Pradesh). The company holds 2 GST registrations, of which 1 is active. It is a listed company as per MCA records. Its shares are listed on BSE: 512217.

The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹13.56 Cr. It is led by directors including Sakshi Laller (Whole-Time Director) and Davender Singh.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Suketi Road, Kala Amb, Himachal Pradesh, India – 173030.

As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹2.44 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹33 Lakh (net margin 13.5%) and EBITDA of ₹41 Lakh (EBITDA margin 16.8%). The net worth stands at ₹15.41 Cr (up 2.1% YoY). Total assets are valued at ₹15.41 Cr (up 2.1% YoY).

The company is associated with 1 brand: Prism Medico. Court records list 1 case involving the company, including 1 filed by the company. The company has 474 deals on record (474 market trades); the latest was in May 2026. The company has 1 MSME Form 1 return on record for the period ending Sep 2019, listing 21 overdue payments to 1 micro and small supplier.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website prismmedico.com.

Company details

CIN L24100HP2002PLC009299
Registration Number 009299
Incorporation Date 22 March 2002
ROC Himachal Pradesh
Listing Status Listed - Listed on BSE (512217)
Company Status Active
Compliance Status Active Compliant

CIN history

Prism Medico and Pharmacy has 5 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24100HP2002PLC009299, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L24100HP2002PLC009299Current
L51109HP2002PLC009299Previous
U51109WB2002PLC094419Previous
L51109MH2002PLC206595Previous
L51109WB2002PLC094419Previous
L51109PB2002PLC047444Previous

Contact details

Prism Medico and Pharmacy Limited's registered office is in Kala Amb, Himachal Pradesh. Its website is prismmedico.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Suketi Road, Kala Amb, Himachal Pradesh, India – 173030
  • Industry
    Chemicals and Materials, Industrial Chemicals

To see the full contact details of Prism Medico and Pharmacy Limited, buy the company report.

Comprehensive company report
Prism Medico and Pharmacy Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Prism Medico and Pharmacy operates one associated brand: Prism Medico. Each brand links to its own profile.

BrandDescriptionWebsite
Drugs for multiple therapeutic areas are manufactured through R&D efforts.prismmedico.in

Financials of Prism Medico and Pharmacy Limited

FY 2025-26 filings available

Prism Medico and Pharmacy Limited reported revenue of ₹2.44 Cr (up 287.3% YoY) for FY 2025-26.

Financial Highlights

FY 2018-19 · Consolidated
Revenue
₹54.43 Cr
+138.7% YoY
EBITDA
₹0.12 Cr
-84.2% YoY
Profit After Tax
₹0.16 Cr
+633.3% YoY
Net Worth
₹12.91 Cr
+0.3% YoY
Total Assets
₹15.21 Cr
+0.9% YoY
Total Debt
₹2.27 Cr
+4.1% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2018-19FY 2017-18FY 2016-17
Income statement
Revenue54.4322.805.27
Revenue growth+138.7%+332.6%-
EBITDA0.120.760.07
EBITDA margin+0.2%+3.3%+1.3%
Profit before tax(0.07)0.06(0.21)
Net profit0.16(0.03)(0.22)
Net profit margin+0.3%-0.1%-4.2%
EPS (₹)0.070.000.00
Balance sheet
Total assets15.2115.0716.38
Net worth12.9112.8712.87
Total debt2.272.183.50
Cash & bank0.411.361.95
Net working capital4.853.186.42
Cash flow
Cash from operations(0.44)3.550.00
Cash from investing0.00(2.53)0.00
Cash from financing(0.50)(1.61)0.00
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue2.440.632.931.278.4416.7626.89
Revenue growth+287.3%-78.5%+130.7%-85.0%-49.6%-37.7%-
EBITDA0.41(0.08)(0.13)(0.10)(0.50)(0.17)(0.05)
EBITDA margin+16.8%-12.7%-4.4%-7.9%-5.9%-1.0%-0.2%
Profit before tax0.44(0.06)(0.03)(0.11)(0.51)(0.18)(0.07)
Net profit0.33(0.04)(0.02)(0.08)(0.38)(0.13)(0.05)
Net profit margin+13.5%-6.4%-0.7%-6.3%-4.5%-0.8%-0.2%
EPS (₹)0.53(0.08)(0.04)(0.13)(0.61)(0.21)(0.08)
Balance sheet
Total assets15.4115.0915.1415.1612.5512.9313.06
Net worth15.4115.0915.1415.1612.5512.9213.05
Total debt0.000.000.000.000.000.000.00
Cash & bank0.060.070.080.100.060.080.11
Net working capital15.2514.8314.8914.9212.3210.8611.04
Cash flow
Cash from operations0.00(0.02)(0.01)2.95(2.38)(0.05)(4.36)
Cash from investing0.000.000.00(2.91)2.350.024.36
Cash from financing0.000.00(0.01)0.000.000.000.00
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue0.180.000.280.070.501.590.070.21
Revenue growth (YoY)-64.0%-100.0%+300.0%-66.7%+72.4%+2550.0%--
Other income0.260.090.000.010.020.000.010.00
Total expenses0.220.150.410.090.600.940.060.22
EBITDA(0.04)(0.15)(0.13)(0.02)(0.10)0.650.01(0.01)
EBITDA margin-22.2%--46.4%-28.6%-20.0%+40.9%+14.3%-4.8%
Depreciation0.000.000.000.000.000.000.000.00
Interest0.000.000.000.000.000.000.000.00
Profit before tax0.22(0.06)(0.13)(0.01)(0.08)0.650.02(0.01)
Tax0.000.000.120.000.00(0.01)(0.02)0.00

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 16 Nov 2026
ParticularsFY 2018-19FY 2017-18FY 2016-17
Revenue54.4322.805.27
Revenue growth+138.7%+332.6%-
Other income0.300.040.07
Total expenses54.3122.045.20
Employee cost0.270.210.28
EBITDA0.120.760.07
EBITDA margin+0.2%+3.3%+1.3%
Depreciation0.380.450.21
Interest0.110.290.14
Profit before tax(0.07)0.06(0.21)
Tax(0.13)0.070.01
Net profit0.16(0.03)(0.22)
Net profit margin+0.3%-0.1%-4.2%
EPS (₹)0.070.000.00
ParticularsFY 2018-19FY 2017-18FY 2016-17
Equity & liabilities
Share capital6.066.066.06
Reserves & surplus6.856.816.81
Shareholders' funds (net worth)12.9112.8712.87
Minority interest0.000.000.00
Secured loans2.271.250.27
Unsecured loans0.000.933.23
Total debt2.272.183.50
Total liabilities15.2115.0716.38
Assets
Gross block10.2210.2310.44
Net block8.919.319.91
Capital work in progress0.000.000.00
Investments1.362.610.00
Inventories1.391.493.41
Sundry debtors3.130.000.71
Cash & bank balances0.411.361.95
Loans & advances5.920.981.23
Total current assets10.853.837.30
Total current liabilities6.000.650.88
Net working capital4.853.186.42
Total assets15.2115.0716.38
ParticularsFY 2018-19FY 2017-18FY 2016-17
Opening cash1.351.950.00
Net cash from operating activities(0.44)3.550.00
Net cash from investing activities0.00(2.53)0.00
Net cash from financing activities(0.50)(1.61)0.00
Net change in cash(0.95)(0.59)0.00
Closing cash0.411.361.95
ParticularsFY 2018-19FY 2017-18FY 2016-17
Growth
Sales growth+138.7%+332.6%-
EBITDA growth-84.2%+985.7%-
PBT growth-+9998.0%+9997.0%
Net income growth+633.3%+86.4%-
Profitability & leverage
Net income margin+0.1%-0.0%-4.2%
Return on capital employed+1.6%+2.8%-0.4%
Return on net worth+1.1%-0.2%-1.7%
Debt / equity0.170.220.27
Long-term debt / equity0.000.120.23
Interest cover-42.3193.55-100.00
Efficiency & per share
Fixed asset turnover5.322.210.53
Inventory turnover37.809.311.64
Debtors turnover34.7864.237.86
EPS (₹)0.070.000.00
Dividend per share (₹)0.000.000.00
Book value per share (₹)21.2921.2321.24
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue0.180.000.280.070.501.590.070.21
Revenue growth (YoY)-64.0%-100.0%+300.0%-66.7%+72.4%+2550.0%--
Other income0.260.090.000.010.020.000.010.00
Total expenses0.220.150.410.090.600.940.060.22
EBITDA(0.04)(0.15)(0.13)(0.02)(0.10)0.650.01(0.01)
EBITDA margin-22.2%--46.4%-28.6%-20.0%+40.9%+14.3%-4.8%
Depreciation0.000.000.000.000.000.000.000.00
Interest0.000.000.000.000.000.000.000.00
Profit before tax0.22(0.06)(0.13)(0.01)(0.08)0.650.02(0.01)
Tax0.000.000.120.000.00(0.01)(0.02)0.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue2.440.632.931.278.4416.7626.89
Revenue growth+287.3%-78.5%+130.7%-85.0%-49.6%-37.7%-
Other income0.030.020.120.000.000.000.00
Total expenses2.030.713.061.378.9416.9326.94
Employee cost0.060.040.030.050.190.170.22
EBITDA0.41(0.08)(0.13)(0.10)(0.50)(0.17)(0.05)
EBITDA margin+16.8%-12.7%-4.4%-7.9%-5.9%-1.0%-0.2%
Depreciation0.000.000.010.010.010.010.02
Interest0.000.000.010.000.000.000.00
Profit before tax0.44(0.06)(0.03)(0.11)(0.51)(0.18)(0.07)
Tax0.11(0.02)(0.01)(0.03)(0.13)(0.05)(0.02)
Net profit0.33(0.04)(0.02)(0.08)(0.38)(0.13)(0.05)
Net profit margin+13.5%-6.4%-0.7%-6.3%-4.5%-0.8%-0.2%
EPS (₹)0.53(0.08)(0.04)(0.13)(0.61)(0.21)(0.08)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital6.066.066.066.066.066.066.06
Reserves & surplus9.359.039.089.106.496.866.99
Shareholders' funds (net worth)15.4115.0915.1415.1612.5512.9213.05
Secured loans0.000.000.000.000.000.000.00
Unsecured loans0.000.000.000.000.000.000.00
Total debt0.000.000.000.000.000.000.00
Total liabilities15.4115.0915.1415.1612.5512.9313.06
Assets
Gross block0.030.030.030.030.050.220.22
Net block0.030.030.030.030.050.060.07
Capital work in progress0.000.000.000.000.000.000.00
Investments0.000.000.000.000.001.941.94
Inventories6.776.776.776.776.774.850.05
Sundry debtors3.933.583.694.764.8813.5118.34
Cash & bank balances0.060.070.080.100.060.080.11
Loans & advances4.694.884.453.520.631.041.07
Total current assets15.4515.3014.9915.1512.3419.4819.57
Total current liabilities0.200.470.100.230.028.628.53
Net working capital15.2514.8314.8914.9212.3210.8611.04
Total assets15.4115.0915.1415.1612.5512.9313.06
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.070.080.100.060.080.110.12
Net cash from operating activities0.00(0.02)(0.01)2.95(2.38)(0.05)(4.36)
Net cash from investing activities0.000.000.00(2.91)2.350.024.36
Net cash from financing activities0.000.00(0.01)0.000.000.000.00
Net change in cash0.00(0.02)(0.01)0.04(0.03)(0.03)(0.01)
Closing cash0.060.070.080.100.060.080.11
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+287.3%-78.5%+130.7%-85.0%-49.6%-37.7%-
EBITDA growth+612.5%+38.5%-30.0%+80.0%-194.1%-240.0%-
PBT growth+9998.0%-100.0%+72.7%+78.4%-183.3%-157.1%-
Net income growth+925.0%-100.0%+75.0%+79.0%-192.3%-160.0%-
Revenue CAGR (3Y)+24.3%-57.9%-44.1%-63.9%-38.5%-7.2%+568.5%
EBITDA CAGR (3Y)--45.7%-8.6%+26.0%---43.7%
Profitability & leverage
Net income margin+13.5%-6.4%-0.7%-6.3%-4.5%-0.8%-0.2%
Return on capital employed+2.8%-0.5%-0.1%-0.8%-3.9%-1.4%-0.5%
Return on net worth+2.1%-0.3%-0.1%-0.6%-2.9%-1.0%-0.4%
Debt / equity0.000.000.000.000.000.000.00
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover0.000.00-7.140.000.000.000.00
Efficiency & per share
Fixed asset turnover81.3321.0097.6731.7562.5276.18122.23
Inventory turnover0.360.090.430.191.456.8453.25
Debtors turnover0.650.170.690.260.921.052.43
EPS (₹)0.53(0.08)(0.04)(0.13)(0.61)(0.21)(0.08)
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)25.4224.8924.9725.0120.7121.3221.53

To see the full year-wise statements and ratios of Prism Medico and Pharmacy Limited, buy the company report.

Board of directors of Prism Medico and Pharmacy Limited

Prism Medico and Pharmacy has 4 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Davender SinghDirector31 Jan 20224 Years 9 MonthsCurrent
Pardeep KumarDirector31 Jan 20224 Years 9 MonthsCurrent
Dinesh KumarDirector14 Aug 20233 Years 3 MonthsCurrent
Sakshi LallerWhole-Time Director16 May 20233 Years 6 MonthsCurrent

Auditor

Prism Medico and Pharmacy Limited is audited by HARJEET PARVESH & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
HARJEET PARVESH & CO.FY 2023017437N

Shareholding

Shareholding for the quarter ended Mar 2026: promoters hold 25.50%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 74.50%.

Promoters: 25.50%Retail & Others: 74.50%
Mar 2026
QUARTER
25.50% Promoters
74.50% Retail & Others
Promoter holding - history
Now 25.50% · Mar 2026High 25.50% · Mar 2026Low 25.00% · Jun 2025
24%24.8%25.5%26.3%27%Jun 2025Sep 2025Dec 2025Mar 2026Jun 2025: 25.00%Sep 2025: 25.00%Dec 2025: 25.00%Mar 2026: 25.50%25.00%25.50%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025
Promoters25.50%25.00%25.00%25.00%
Public74.50%75.00%75.00%75.00%

Deals & funding

Prism Medico and Pharmacy Limited has 474 deals on record (474 market trades); the latest was in May 2026.

Total deals
474
Market trades
474

Deals on record (5 of 474)

WhenDealAmountParties
Mar 2026Market trade₹63.4 LakhBuyer: 4 individuals
Seller: Neo Apex Share Broking Services LLP , 2 individuals
Mar 2026Market trade₹9.4 LakhSeller: Neo Apex Share Broking Services LLP
Mar 2026Market trade₹1.66 CrBuyer: Neo Apex Share Broking Services LLP , Gala Finance and Investment Private Limited
Seller: Neo Apex Share Broking Services LLP , 2 individuals
Aug 2025Market trade₹5.8 LakhBuyer: Gala Finance and Investment Private Limited
Seller: an individual
Mar 2025Market trade₹6.8 LakhBuyer: Mukesh Commercial Pvt Ltd
Seller: Nopea Capital Services Private Limited

To see the full deal history of Prism Medico and Pharmacy Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Prism Medico and Pharmacy Limited has 1 MSME Form 1 return on record for the period ending Sep 2019, listing 21 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (1 of 1)

SupplierAmount dueDue sinceReported on
Ajooni Biotech Limited

To see the full MSME payment records of Prism Medico and Pharmacy Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Prism Medico and Pharmacy has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
02AAACW0505H1Z0Himachal PradeshActive09 Feb 2022

To see the full GST registrations and return filing status of Prism Medico and Pharmacy Limited, buy the company report.

Recent activity

Prism Medico and Pharmacy Limited has 17 board changes on record since 2009: 8 appointments and 9 cessations. The latest: Vishwambhar Dayal Gupta ceased to be Director on 14 Nov 2024.

Filing
Prism Medico And Pharmacy Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Himachal Pradesh.
AGM
Prism Medico And Pharmacy Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Vishwambhar Dayal Gupta ceased to be Director.
Appointed
Dinesh Kumar was appointed as Director.
Ceased
Gursimran Singh ceased to be CFO.
Ceased
Ramandeep Singh ceased to be Whole-Time Director.
Appointed
Sakshi Laller was appointed as Whole-Time Director.
Ceased
Simmi Chhabra ceased to be Director.
Appointed
Vishwambhar Dayal Gupta was appointed as Director.
Appointed
Davender Singh was appointed as Director.
Appointed
Pardeep Kumar was appointed as Director.
Appointed
Ramandeep Singh was appointed as Whole-Time Director.

8 earlier events are in the company report.

Frequently asked questions

Prism Medico and Pharmacy is an active public limited company based in Kala Amb, Himachal Pradesh, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 22 March 2002 (24+ years old) and is registered under CIN L24100HP2002PLC009299. Listed on BSE: 512217.

Prism Medico and Pharmacy reported revenue of ₹2.44 Cr for FY 2025-26 (up 287.3% YoY) based on standalone financials.

Prism Medico and Pharmacy has 4 current directors:

The latest financial statements of Prism Medico and Pharmacy on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Prism Medico and Pharmacy is 02AAACW0505H1Z0, registered in Himachal Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Prism Medico and Pharmacy is L24100HP2002PLC009299. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Prism Medico and Pharmacy is a listed company as per MCA records. Its shares are listed on BSE (code: 512217).

Prism Medico and Pharmacy has 1 court case on record: 1 filed by the company.

Prism Medico and Pharmacy was incorporated on 22 March 2002, making it 24+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.

Prism Medico and Pharmacy has 474 deals on record (474 market trades); the latest was in May 2026.

Vishwambhar Dayal Gupta ceased to be Director on 14 Nov 2024. Dinesh Kumar was appointed as Director on 14 Aug 2023. Gursimran Singh ceased to be CFO on 16 May 2023. Prism Medico and Pharmacy has 17 board changes on record in total.